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Abstract
Background: Both resveratrol and vitamin C (ascorbic acid) are frequently used in complementary and alternative
medicine. However, little is known about the underlying mechanisms for potential health benefits of resveratrol
and its interactions with ascorbic acid.
Methods: The antioxidant enzymes heme oxygenase-1 and paraoxonase-1 were analysed for their mRNA and
protein levels in HUH7 liver cells treated with 10 and 25 μmol/l resveratrol in the absence and presence of 100 and
1000 μmol/l ascorbic acid. Additionally the transactivation of the transcription factor Nrf2 and paraoxonase-1 were
determined by reporter gene assays.
Results: Here, we demonstrate that resveratrol induces the antioxidant enzymes heme oxygenase-1 and
paraoxonase-1 in cultured hepatocytes. Heme oxygenase-1 induction by resveratrol was accompanied by an
increase in Nrf2 transactivation. Resveratrol mediated Nrf2 transactivation as well as heme oxygenase-1 induction
were partly antagonized by 1000 μmol/l ascorbic acid.
Conclusions: Unlike heme oxygenase-1 (which is highly regulated by Nrf2) paraoxonase-1 (which exhibits fewer
ARE/Nrf2 binding sites in its promoter) induction by resveratrol was not counteracted by ascorbic acid. Addition of
resveratrol to the cell culture medium produced relatively low levels of hydrogen peroxide which may be a
positive hormetic redox-signal for Nrf2 dependent gene expression thereby driving heme oxygenase-1 induction.
However, high concentrations of ascorbic acid manifold increased hydrogen peroxide production in the cell culture
medium which may be a stress signal thereby disrupting the Nrf2 signalling pathway.
Background
Resveratrol (3,4’,5-trihydroxy-trans-stilbene) is a second-
ary plant metabolite which is highly abundant in red
g r a p es k i na n dr e dw i n e[ 1 ] .O t h e rd i e t a r ys o u r c e so f
resveratrol comprise berries, and peanuts [2,3]. Although
controversially discussed it has been recently shown that
resveratrol may increase life span in model organisms
such as Caenorhabditis elegans and Drosophila melano-
gaster [4-6]. The underlying mechanisms by which
resveratrol may mediate beneficial effects have yet not
been fully understood and may be partly related to its
ability to induce phase II and antioxidant enzymes
including heme oxygenase-1 and paraoxonase-1.
Heme oxygenase-1 (HO-1), is an inducible enzyme
that catalyzes the rate-limiting step in the oxidative
degradation of cellular heme that liberates iron, carbon
monoxide (CO), and biliverdin. HO-1 exhibits antioxi-
dant, anti-inflammatory and other cytoprotective func-
tions [7].
Paraoxonase-1 (PON1) is a HDL associated serum
enzyme which is mainly synthesized in the liver. PON1
may mediate anti-atherogenic properties by protecting
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deficient mice are highly susceptible towards athero-
sclerosis [9] whereas paraoxonase overexpression
represses atherogenesis and promotes atherosclerotic
plaque stability in mice [10].
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a
transcription factor that positively regulates the basal
and inducible expression of a large battery of cytopro-
tective genes [11-13]. Following induction, Nrf2 is disso-
ciated from the Keap1-Nrf2 complex, translocates to the
nucleus where it binds to the antioxidant response ele-
ment (ARE) to increase the expression of cytoprotective
genes including HO-1.
Vitamin C (ascorbic acid) is an essential micronutrient
in primates which exhibits some of its biological activity
due to its free radical scavenging activity. Ascorbate is a
water-soluble chain-breaking radical scavenger and
recycles plasma membrane a-tocopherol via the reduc-
tion of the a-tocopheroxyl radical [14].
Beside antioxidant also prooxidant activities of ascorbic
acid have been described [15,16]. Ascorbic acid promotes
the Fenton reaction in vitro and may accelerate non
enzymatic lipid peroxidation in various tissues [17].
Furthermore, pharmacological doses of ascorbate pro-
duced sustained ascorbate radical and hydrogen peroxide
formation in mice [18]. Both resveratrol and ascorbic
acid are frequently used in complementary and alterna-
tive medicine [19-22]. Little is known about interactions
between resveratrol and ascorbic acid regarding the
expression of genes encoding for antioxidant enzymes.
Therefore in this study we have investigated if ascorbic
acid affect resveratrol mediated induction of HO-1 and
PON-1 gene expression. We have selected the two genes
since they are centrally involved in cellular antioxidant
defence mechanisms. Furthermore, both genes signifi-
cantly differ in their number of ARE binding sites in their
promoter region. ARE is an important binding motif for
the redox regulated transcription factor Nrf2 which
partly controls phase II and antioxidant gene expression.
Methods
In silico Analysis
For promoter analysis, sequences of HO-1 and PON1
genes were uploaded to MatInspector Software http://
www.genomatix.de in order to identify putative binding
sites for Nrf2. The respective promoter sequences were
obtained from Ensembl genome browser http://www.
ensembl.org and were adjusted to 2000 bp upstream
and 600 bp downstream of transcriptional start site.
Cell Culture
HUH7 human hepatoma cells (obtained from the Insti-
tute of Applied Cell Culture, Munich, Germany), were
cultured in high glucose (4 g/l) Dulbecco’sm o d i f i e d
Eagle’s medium supplemented with 10% (v/v) foetal
bovine serum, 4 mmol/l L-glutamine, 100 U/ml penicil-
lin and 100 μg/ml streptomycin (all PAA, Coelbe, Ger-
many) and grown in a humidified incubator at 37°C and
5% CO2. HUH7/PON1 cells were cultivated in high glu-
cose (4 g/l) Dulbecco’s modified Eagle’s medium with
10% heat inactivated foetal bovine serum, 100 U/ml
penicillin, 100 μg/ml streptomycin and 100 μg/ml G418
(all from PAA, Coelbe, Germany). For cell culture stu-
dies stock solutions were prepared as following: 100
mmol/l resveratrol (Sigma, Deisenhofen, Germany) dis-
solved in DMSO, and stored at -80°C until further use;
1 mol/l ascorbic acid (Carl Roth, Karlsruhe, Germany)
was freshly prepared in PBS and adjusted to pH 7. For
all cell culture assays vehicle controls have been per-
formed and did not affect any of the parameters
measured.
Cytotoxicity
The neutral red assay [23,24] was used to determine the
cell viability after incubation with the different test com-
pounds. HUH7 cells were seeded at a density of 0.2 ×
10
6 cells/well (for HUH7) or 0.15 × 10
6 cells/well (for
HUH7/PON1) for 24 h and treated with 5-100 μmol/l
resveratrol and 10-1000 μmol/l ascorbic acid, respec-
tively. HUH7 cells were incubated with test compounds
for 24 h, HUH7/PON1 cells for 48 h. In brief, the cul-
ture medium containing the test substances was
replaced with fresh serum-containing medium including
60 μg/ml of Neutral Red (Carl Roth, Karlsruhe, Ger-
many). After incubation for 1.5 h the medium was
removed and the cells were extracted using a solution
comprising 50:49:1 (v/v/v) ethanol, water and glacial
acetic acid. The absorbance was measured in a plate
reader (Labsystems, Helsinki, Finland) at 540 nm.
RNA isolation and real time PCR
HUH7 cells were seeded at a density of 1.0 × 10
6 cells/
well in a 6 well plate for 24 h. Subsequently, cells were
treated with resveratrol (10 μmol/l) alone and in combi-
nation with 100 μmol/l and 1000 μmol/l ascorbic acid for
6 h, respectively. RNA was isolated using TRIsure (Bio-
line, Luckenwalde, Germany) according to manufac-
turer’s instructions. Primers for human HO-1 gene
(forward 5’CCAGGCAGAGAATGCTGAGT 3’; reverse
5’ GTAGACAGGGGCGAAGACTG3’)w e r ed e s i g n e db y
Primer3 software and ordered at MWG Biotech/Eurofins,
Ebersberg, Germany. Real time PCR was performed with
a SensiMix one step kit (Quantace, Berlin, Germany).
Stable transfection and luciferase reporter gene analysis
for PON1
PON1 induction capacity of resveratrol in the presence
of ascorbic acid was evaluated in cultured hepatocytes.
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stably transfected with a reporter plasmid containing
1009 bp [-1013, -4] of the PON1 gene 5’-region cloned
into the firefly luciferase reporter vector pGL3 basic
(Promega) as described previously [25]. Stable clones
originated from X. Coumoul/R. Barouki, INSERM,
France. HUH7/PON1 cells were seeded at an initial den-
sity of 150,000 cells per well (24 well plate) and incu-
bated with 25 μmol/l resveratrol (Sigma, Deisenhofen,
Germany) in the absence or presence of ascorbic acid
(100 and 1000 μmol/l) for 48 h as recently described
[26]. Then, the cells were washed with PBS, lysed and
subjected to luciferase activity measurement (Luciferase
assay system; Promega, Madison, WI, USA) by lumines-
cence reading (Infinite 200 reader; Tecan, Crailsheim,
Germany) and normalized to total cell protein (BCA
Assay, Pierce, Illinois, USA).
Transient transfection and luciferase reporter gene
analysis for Nrf2
HUH7 cells were seeded in a 24-well-plate at a density
of 0.1 × 10
6 cells for 24 h. Then cells were transfected
with pARE_GIGPx_Luc (kindly provided by A. Banning/
R. Brigelius-Flohé, DIFE, Potsdam, Germany), a lucifer-
ase reporter gene under the control of the ARE region
found in the promoter of the human GIGPx, as
described by Banning et al. 2005 [27]. The renilla repor-
ter gene phRLTK (Promega, Mannheim, Germany) was
applied for normalization. Both plasmids were trans-
fected by using FuGene6 (Roche, Penzberg, Germany)
according to manufacturer’s protocol. 24 h post trans-
fection medium was removed and the cells were simul-
taneously treated with 10 μmol/l resveratrol and 100
and 1000 μmol/l ascorbic acid for further 24 h. Follow-
ing lysis with passive lysis buffer (Promega, Mannheim,
Germany) firefly and renilla luciferase activity was deter-
mined using the Dual Luciferase Assay (Promega, Man-
nheim, Germany) according to manufacturer’s
description. Firefly luciferase values were normalized by
renilla luciferase values. The experimental data represent
the mean of three independent experiments performed
in duplicate.
Western Blotting
For HO-1 and PON1 detection cells were treated with
the test compounds for 24 h. Subsequently, cells were
washed with ice-cold PBS, scraped off, centrifuged and
the remaining cell pellet was stored at -80°C. For Wes-
tern Blotting, the cell pellet was lysed in RIPA buffer
[50 mmol/l Tris-HCl, 150 mmol/l NaCl, 0.5% (w/v)
sodium deoxycholate, 0.1% (w/v) sodium dodecyl sul-
phate (SDS), 1% (w/v) Nonidet-P40, 2 mmol/l EDTA, 1
mmol/l dithiothreitol (DTT), protease inhibitor cocktail
(Sigma, Deisenhofen, Germany)] and stored until further
analysis. Protein concentrations were determined with
the BCA assay (Pierce, Illinois, USA) according to man-
ufacturer’si n s t r u c t i o n s .4 0μg protein of each sample
were mixed with loading buffer, denatured at 95°C for 5
min and separated on a 12% SDS PAGE. Subsequently
the samples were transferred onto a PVDF membrane
and blocked with 5% (w/v) skim milk dissolved in TBS
+0.05% (v/v) Tween-20 (TBST) for at least 1 h and
probed with HO-1 (Stressgen, Michigan, USA; 1:1000)
or PON1 (Abcam, Cambridge, UK; 1:1000) at 4°C over
night. Following, the membranes were incubated with a
secondary antibody (1:4000 anti-rabbit) for 45 min and
the bands were visualized by using ECL reagent in a
ChemiDoc XRS system (both BioRad, Munich,
Germany).
Fox Assay
Fox assay was carried out according to Long and cowor-
kers [28]. Tests were performed in DMEM high glucose
medium supplemented with 10% fetal bovine serum and
100 U/ml of penicillin and 100 μg/ml streptomycin.
DMEM was supplemented with increasing concentra-
tions of resveratrol (1, 5, 10, 25, 50 μmol/l) in combina-
tion with 100 and 1000 μmol/l ascorbic acid (adjusted to
pH 7), respectively. A standard curve was prepared using
H2O2 ( 0 ,2 . 2 ,8 . 8 ,2 2 ,8 8μmol/l). The samples were
m i x e dw i t hF O Xr e a g e n ta n di n c u b a t e da tr o o mt e m -
perature for 30 min. Following centrifugation at 15,000 ×
g for 4 min the absorbance was read at 560 nm.
Statistical Analysis
Statistical analysis was conducted using SPSS software
Version 15.0 (Munich, Germany). Data were analysed
for normality of distribution (Kolmogorov-Smirnov or
Shapiro-Wilk-test). In case of not normally distributed
data the non-parametric Mann-Whitney-U test was
applied. One-way analysis of variance (ANOVA) with a
Dunnet’s (homogeneous variances) or Games-Howell
(heterogenous variances) post hoc test was performed.
Data are expressed as mean ± SEM. Significance was
accepted at p < 0.05.
Results
1) In silico analysis
To identify binding sites for Nrf2 in promoter regions of
HO-1 and PON1, the respective promoter sequences
were uploaded to MatInspector.A ss h o w ni nf i g u r e s1 a
and 1b, four alternative promoter sequences have been
identified for both HO-1 and PON1 genes. Importantly,
binding sites (in total eight) for Nrf2 have been identi-
fied in all promoter sequences of HO-1 (Figure 1a).
However, for the PON1 gene, only three promoter
sequences have been identified comprising in total five
Nrf2 binding sites (Figure 1b).
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Page 3 of 82) Cell culture experiments
Resveratrol was not cytotoxic up to a concentration of
25 μmol/l. At 50 μmol/l resveratrol a slight 10%
decrease in cell viability was observed (Figure 2a).
Ascorbic acid (Figure 2b) did not exhibit any cytotoxi-
city up to a concentration of 1000 μmol/l each.
Incubation of HUH7 cells with 10 μmol/l resveratrol
resulted in a significant increase in HO1 mRNA (Figure
3a) and protein levels (Figure 3b). Coincubation of
resvertraol with ascorbic acid partly counteracted resver-
atrol mediated HO-1 induction.
HO-1 gene expression is highly regulated by the tran-
scription factor Nrf2. Therefore we determined Nrf2
transactivation in the absence and presence of resvera-
trol and ascorbic acid. Resveratrol significantly enhanced
Nrf2 transactivation (3.5 fold increase as compared to
untreated cells). Coincubation of resveratrol with 1000
μmol/l ascorbic acid antagonized resveratrol mediated
Nrf2 induction (Figure 4).
Incubation of HUH7 cells stably transfected with
PON1 with resveratrol significantly increased PON1
transactivation (Figure 5a). Ascorbic acid concentration
of 100 μmol/l did not affect PON1 transactivation,
whereas 1000 μmol/l ascorbic acid slightly enhanced
PON1 transactivation. Furthermore resveratrol induced
PON1 protein levels in HUH7 cells. The induction of
PON1 due to resveratrol was not counteracted by ascor-
bic acid (Figure 5b)
3) Fox-Assay
As shown in figure 6 resveratrol per se produced rela-
tively low amounts (1.3-1.6 μmol/l) of hydrogen perox-
ide in the DMEM cell culture medium as determined
with the Fox assay. The addition of 100 μmol/l and
1000 μmol/l ascorbic acid resulted in a dose-dependent
increase in hydrogen peroxide formation. At 100 μmol/l
ascorbic acid ~15 μmol/l hydrogen peroxide and at
a
b
Figure 1 Nrf2 binding sites in alternative promoter sequences
of the HO-1 and PON1 gene. Nrf2 binding sites are depicted in
alternative promoter sequences of (a) HO-1 (GXP_58427,
GXP_1266732, GXP_2244641, GXP_2244642) and (b) PON1
(GXP_116467, GXP_116468, GXP_116678, GXP_2253723) relative to
transcription start site (red arrow).
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Figure 2 Cytotoxicity of resveratrol and ascorbic acid. Effects of
resveratrol (a) and ascorbic acid (b) on cell viability in HUH7 cells.
Data are mean ± SEM of at least 2 experiments performed in
triplicate.
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peroxide were generated.
Discussion
In the present study we demonstrate that ascorbic acid
partly antagonizes resveratrol mediated HO-1 but not
PON1 induction in cultured human hepatocytes.
Resveratrol is known to induce HO-1 in cell culture as
well as in the liver of laboratory rats [29-31]. As far as
the concentrations of the test components are con-
cerned administered ascorbic acid concentrations, as
used in our cell culture exper i m e n t s ,a r eb yi nl a r g ei n
the physiological range [32]. However, resveratrol con-
centrations used in this study in order to induce HO-1
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Figure 3 Effects of resveratrol and ascorbic acid on HO-1
mRNA and protein levels. mRNA (a) and protein levels (b) of HO-1
in HUH7 cells in response to resveratrol supplementation in the
absence and presence of 100 and 1000 μmol/l ascorbic acid. Data
are mean ± SEM of at least 3 experiments performed in triplicate. #
indicates significant difference between control and 10 μmol/l
resveratrol p < 0.05, Mann-Whitney-U-Test.
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Figure 4 Effects of resveratrol and ascorbic acid on Nrf2
transactivation. HUH7 cells were supplemented with resveratrol in
the absence and presence of 100 and 1000 μmol/l ascorbic acid.
Data are mean ± SEM of at least 3 experiments performed in
triplicate. # indicates significant difference between control and 10
μmol/l resveratrol p < 0.05, Mann-Whitney-U-Test; * indicates
significant differences compared to 10 μmol/l resveratrol p < 0.05,
Mann-Whitney-U-Test.
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HUH7/PON1 cells supplemented with resveratrol in the absence and
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PON1 in HUH7 cells in response to resveratrol supplementation in
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Data are mean ± SEM of at least 2 experiments performed in
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Figure 6 Production of hydrogen peroxide by resveratrol and
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humans [33]. Interestingly, under the conditions investi-
gated, ascorbic acid counteracted the induction of HO-1
by resveratrol. Ascorbic acid is a water soluble cytosolic
antioxidant. Thus the decrease in HO-1 mRNA and
protein levels due to ascorbic acid may be mediated by
effects which occur in the cytosol.
Although ascorbic acid moderately antagonized resver-
atrol mediated HO-1 induction we have found no antag-
onistic interaction between resveratrol and ascorbic acid
in terms of PON1 transactivation and its protein levels.
While the HO-1 promoter region contains many Nrf2/
ARE binding sites, PON1 is regulated to a lower extend
by Nrf2. Therefore, we suggest an important role of the
transcription factor Nrf2 in the antagonism between
resveratrol and ascorbic acid regarding HO-1 gene
expression.
Since the addition of 1000 μmol/l ascorbic acid to the
DMEM medium resulted in the production of signifi-
cant levels of hydrogen peroxide as previously described
[ 3 4 ]i tm a yb ep o s s i b l et h a th y d r o g e np e r o x i d ed i r e c t l y
disrupted the Nrf2 signalling pathway leading to a
decreased HO-1 gene expression. Thus under conditions
investigated ascorbic acid exhibited prooxidant activity
which in turn may have attenuated resveratrol induced
HO-1 induction. However, it needs to be taken into
account that the FOX assay is not specific for hydroper-
oxides; also cyclic peroxides and serial-cyclic peroxides
may give positive FOX response [35].
I nt h i sc o n t e x ti th a sb e e nr e c e n t l ys h o w nt h a tf r e e
radicals deriving from cigarette smoke increase protein
carbonyl formation of the Nrf2/Keap1 complex. This
in turn leads to modifications of sulfhydryl groups of
Nrf2/Keap1 which may impair the dissociation of the
Nrf2/Keap1 complex and consequently repressing the
nuclear translocation of Nrf2. The modified Nrf2 may
then undergo proteasomal degradation [36]. Interest-
ingly addition of resveratrol to the cell culture medium
produced in our study low levels of hydrogen peroxide
which may be a positive “hormetic redox-signal” for
Nrf2 dependent gene expression thereby driving HO-1
induction. Contrary ascorbic acid is inducing the pro-
duction of high levels of hydrogen peroxide which may
be considered as a “cellular stress signal” that inter-
feres with the Nrf2 signal transduction cascade thereby
antagonizing HO-1 gene expression (see Figure 7).
Interestingly Ristow and coworkers have recently
demonstrated that ascorbic acid may interfere with
physical exercise related induction of the Nrf2 target
genes superoxide dismutase and glutathione peroxidase
in humans [37].
The generation of reactive oxygen species by ascor-
bic acid, as shown in this cell culture study, my not
be always detrimental. It has been shown that
pharmacological concentrations of ascorbic acid
increased the production of hydrogen peroxide in pan-
creatic cancer cells which in turn resulted in the
induction of caspase-independent cell death and
autophagy [38]. Furthermore, it should be taken into
account that disruption of Nrf2 activity by ascorbic
acid may result in a GSH depletion which could
restore the sensitivity of cancer cells towards antican-
cer drugs such as imatinib [39].
Conclusions
Overall the current study has some limitations: First, our
findings are based on cell culture studies. Thus further
studies in laboratory rodents and in humans are needed
to investigate interactions between resveratrol and
ascorbic acid on HO-1 and PON1 status. Second, the
concentration of resveratrol as used here in cultured
cells to induce HO-1 and PON1 are higher than those
physiologically achievable. Finally we have worked with
purified test components only. It has yet not been inves-
tigated whether the observed interactions between rever-
atrol and ascorbic acid on HO-1 and PON1 status may
also occur when resveratrol and ascorbic acid derive
from a complex diet.
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